CDC20 exacerbates myocardial injury after myocardial infarction by regulating PPARα-mediated cardiomyocytes fatty acid metabolism (ESC 2026) - May 11, 2026 - Pres time: Aug 28, 2026; 11:15 AM - 12:00 PM; Location: Station 11 (Research Gateway (Hall A1)); "CDC20 is a key regulator of metabolic dysfunction in cardiomyocytes after AMI. Lomitapide, which targets CDC20, may become a new and effective drug for treating AMI."
Cardiovascular • Congestive Heart Failure • Heart Failure • Myocardial Infarction • CDC20 • PPARA
|
|
J Pan1; Dan Liu1; Chenghui Yan1; Haixu Song1; Yaling Han1
|